Composition for stabilizing bacteriophage and sterilization method using same

The use of a sorbitol, sodium chloride, and magnesium sulfate composition stabilizes bacteriophages, allowing them to be stored at room temperature for extended periods, addressing the limitations of existing storage methods and ensuring effective antibacterial activity against foodborne pathogens.

WO2024248347A1PCT designated stage expired Publication Date: 2024-12-05KOREA FOOD RES INST
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/006023
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-02
Filing Date
2024-05-03
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current methods for storing bacteriophages are expensive and unsuitable for large-scale storage, as they require refrigeration and have limited shelf life, which hampers the commercialization and preservation of these antibacterial agents used to control foodborne pathogens like E. coli and Salmonella.

Method used

A composition containing sorbitol, sodium chloride, and magnesium sulfate is used to stabilize bacteriophages, allowing them to be stored at room temperature for extended periods without significant loss of antibacterial activity, thereby extending their viability and shelf life.

Benefits of technology

The stabilizing composition maintains the antibacterial activity of bacteriophages for over 60 days, and up to 400 days or more, enabling convenient and economical storage and application on food products to prevent contamination by pathogens like E. coli and Staphylococcus aureus.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024006023_05122024_PF_FP_ABST
    Figure KR2024006023_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a composition for stabilizing a bacteriophage, a bacteriophage composition comprising same, a food packaging material, and a sterilization method using same. The composition for stabilizing bacteriophage according to the present invention can be commercialized and stored in a more convenient, economical, and efficient manner even at room temperature compared to an existing bacteriophage storage method, and is manufactured into a bacteriophage composition comprising the composition for stabilizing bacteriophage or a packaging material coated with bacteriophage, whereby the composition can be directly applied to food for biological control and thus advantageously used for preventing bacterial contamination of food, maintaining food safety, and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Composition for stabilizing bacteriophage and sterilization method using the same

[0001] The present invention relates to a composition for stabilizing bacteriophage, a bacteriophage composition comprising the same, a food packaging material, and a sterilization method using the same.

[0002] Food is highly susceptible to contamination by pathogens during the manufacturing, distribution, and storage processes. Contamination with bacteria not only reduces quality but can also cause food poisoning when consumed. Therefore, it is important to prevent food contamination by pathogens.

[0003] However, despite significant advances in food hygiene technology, various foodborne pathogens continue to threaten human health, leading to hospitalization and death (Elbehiry et al., 2023). Among various foods, fresh produce is a major source of foodborne illness, harboring virulent pathogens such as Escherichia coli, Salmonella, and Listeria monocytogenes. In particular, E. coli threatens the health of millions of people every year, and outbreaks of E. coli O157:H7 infections are very common after consumption of contaminated plant foods (e.g., lettuce, spinach, tomatoes, and fresh fruits) (Puligundla & Lim, 2022). This is because fruits and vegetables are grown in open environments, vulnerable to microbial contamination, and are often not treated to reduce or eliminate pathogens. Since agricultural products are foods that can be eaten immediately without a separate sterilization process, it is important to remove the microbial load during preprocessing stages such as washing or postprocessing stages such as using food-grade disinfectants.

[0004] Accordingly, various methods have been developed and devised to improve the safety of fresh foods. Natural and chemical food preservatives are used to control foodborne outbreaks. Natural preservatives such as organic acids, bacteriocins, chitosan, and lactoferrin have weak antibacterial activity and limited use, while chemical preservatives and antibiotics are more effective but have concerns about side effects. For example, chlorine-based disinfectants are widely used to eliminate microorganisms contaminating fresh foods due to their high antibacterial efficacy. However, concerns about the formation of carcinogenic byproducts, which pose environmental and health risks, are driving their use to decline. To address these issues, many researchers are developing alternative disinfectants.

[0005] Bacteriophages are gaining recognition as effective antibiotics, overcoming the limitations of previous methods. Bacteriophages are viruses that infect and kill bacteria. They specifically bind to target bacteria, multiplying within them and lysing them. Because of their high specificity, phages do not affect the normal, beneficial microflora of the host, food, or environment. Furthermore, they do not adversely affect food quality or animal or human health, eliminating the need for additional removal steps. These advantages allow bacteriophages to be directly applied to food to control foodborne pathogens. Since 2006, bacteriophages have been recognized as generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA). As a safe biological material, they are used as food additives to prevent food contamination by pathogens. Since the initial approval of the bacteriophage formulation, additional bacteriophage products have been approved and marketed, such as Salmo Fresh™ for Salmonella control and EcoShield® for E. coli control.

[0006] Meanwhile, for the development of these phage products and their application to food, phage storage methods and shelf life are crucial. Phage commercialization and preservation can be achieved using aqueous suspension cryopreservation, freeze-drying, encapsulation, and spray drying. Because phage titers rapidly decrease when stored at room temperature, the most commonly used strategy for phage preservation is low-temperature storage, such as 4°C, -20°C, or -80°C. In fact, bacteriophage products such as Salmo Fresh™ for Salmonella control and EcoShield® for E. coli control are distributed in solution form, and the containers are instructed to be stored refrigerated (2-8°C) and protected from light. The main disadvantage of this storage method is that it is expensive and not suitable for large-volume storage. Another method is encapsulation, which protects the phage by wrapping it in a biological material. Encapsulated phage is more resistant to environmental changes during storage and shipping. However, encapsulation technology does not improve the viability of bacteriophage compared to low-temperature storage (including refrigeration), and depending on the application, the development of new storage methods may incur additional costs. Lyophilization is an effective preservation method that maintains structural integrity and extends shelf life by sublimating water from a solid to a gaseous state. This method has the advantage of being easy to store and transport in the form of a dry powder, but the disadvantage is that the process is complex and requires expensive specialized equipment.

[0007] Accordingly, there is a need to develop a more convenient and economical storage method so that the excellent antibacterial activity of bacteriophages against bacteria can be maintained.

[0008] The present invention aims to solve the above-mentioned problems and other problems related thereto.

[0009] An object of the present invention is to provide a composition for stabilizing bacteriophage comprising sorbitol, sodium chloride and magnesium sulfate.

[0010] Another object of the present invention is to provide a bacteriophage composition comprising the above bacteriophage stabilizing composition.

[0011] Another object of the present invention is to provide a coating composition comprising the bacteriophage stabilizing composition, bacteriophage, and a coating material.

[0012] Another object of the present invention is to provide an antibacterial film manufactured using the above coating composition.

[0013] Another object of the present invention is to provide a food packaging material comprising the antibacterial film.

[0014] Another object of the present invention is to provide a method for sterilizing food or food material, comprising a step of treating the food or food material with the bacteriophage composition.

[0015] Another object of the present invention is to provide a method for sterilizing food or food materials, comprising the steps of placing food or food materials into a container packaged with the food packaging material; and the steps of bringing the container into contact with water.

[0016] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below.

[0017]

[0018] As one aspect for achieving the above object, the present invention provides a composition for stabilizing bacteriophage comprising sorbitol, sodium chloride and magnesium sulfate.

[0019] The term 'bacteriophage' of the present invention refers to a bacterium-specific virus that infects a specific bacterium and inhibits and suppresses the growth of the bacterium, and refers to a virus that contains single or double-stranded DNA or RNA as its genetic material.

[0020] The term 'stabilization' of the present invention means that the activity of the bacteriophage, i.e. the antibacterial activity of the bacteriophage, is stably maintained when the bacteriophage is stored in a storage solution containing the stabilizing composition of the present invention, and specifically means extending the maintenance period of the bacteriophage activity. The bacteriophage stabilizing composition of the present invention can be used for the purpose of stably storing, preserving, or maintaining bacteriophage, and can be used for the purpose of maintaining the antibacterial activity of the bacteriophage. The antibacterial activity of the above bacteriophage may be a killing activity against food poisoning bacteria, and specifically, the food poisoning bacteria may be Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus, or Cronobacter sakazakii.

[0021] The composition may comprise sorbitol, sodium chloride and magnesium sulfate, and specifically may comprise 5 to 20% (w / v) sorbitol, 0.1 to 1 M sodium chloride and 5 to 10 mM magnesium sulfate, preferably 10 to 15% (w / v) sorbitol, 0.1 to 0.5 M sodium chloride and 7 to 9 mM magnesium sulfate, and more preferably 10% (w / v) sorbitol, 0.1 M sodium chloride and 8 mM magnesium sulfate.

[0022] The bacteriophage of the present invention may have a specific killing ability against Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus or Cronobacter sakazakii, and preferably may have a specific killing ability against Escherichia coli or Staphylococcus aureus. The bacteriophage may be stored in the stabilizing composition of the present invention at 4 to 30°C, and specifically, may be stored at a temperature that does not require refrigeration by using energy, that is, at room temperature, and preferably may be stored at 20 to 25°C.

[0023] In the present invention, when the bacteriophage is stored in the bacteriophage stabilizing composition of the present invention, it may be maintained for 20 days or more, specifically, it may be maintained for 60 days or more, it may be maintained for 180 days or more, it may be maintained for 300 days or more, it may be maintained for 400 days or more, but is not limited thereto, and preferably, it may be maintained for 60 to 350 days.

[0024] As one aspect for achieving the above purpose, the present invention provides a bacteriophage composition comprising the composition for stabilizing the bacteriophage.

[0025] The above 'bacteriophage', 'stabilization' and 'stabilization composition' are as described above.

[0026] The 'bacteriophage composition' of the present invention comprises 10 bacteriophages. 4 10 inland 12 It may be included as PFU / ml, preferably 6×10 8 6×1010 It may include PFU / ml, but is not limited to this as long as it is within the range of sterilizing effect.

[0027] The above bacteriophage composition may be specifically manufactured as a bacteriophage concentrate containing the bacteriophage stabilizing composition. Specifically, the bacteriophage concentrate may be one in which bacteriophage particles are not suspended in a medium or buffer that cannot be used in food, but are resuspended at an appropriate concentration together with distilled water and the stabilizing composition of the present invention. More specifically, the bacteriophage concentrate may be manufactured by replacing a suspension in which bacteriophage is grown in a bacterial culture medium or a purified bacteriophage solution with a dispersion having a volume three or more times the original volume using a protein concentrator (protein concentration, MWCO 100 kDa).

[0028] As one aspect for achieving the above object, the present invention provides a coating composition comprising the bacteriophage stabilizing composition, bacteriophage, and a coating material.

[0029] The above 'bacteriophage', 'stabilization', and 'stabilization composition' are as described above.

[0030] The term 'coating material' of the present invention refers to a material used to coat the outer surface of an object with a thin film of resin or the like.

[0031] The above 'coating material' may be pullulan, carboxymethyl cellulose (CMC), or polyvinyl alcohol (PVA), preferably pullulan or carboxymethyl cellulose, and more preferably pullulan, but is not limited thereto. The 'pullulan' may be 5 to 10% pullulan, and preferably 5% pullulan, but is not limited thereto. In addition, the 'carboxymethyl cellulose (CMC)' may be 1% CMC, but is not limited thereto, and the 'polyvinyl alcohol (PVA)' may be 5 to 10% PVA, and preferably 5% PVA, but is not limited thereto.

[0032] In the present invention, the term 'coating' may include the concept of covering the outer surface of an object with a thin film or applying it by spreading it on the outer surface of an object.

[0033] In the present invention, the coating composition may further include a solvent.

[0034] In the present invention, the coating composition may be manufactured by adding a coating material and the stabilizing composition of the present invention to distilled water, applying heat, mixing the mixture using a magnetic bar for 30 minutes to 2 hours, filtering the solution, and then adding phage to the mixture. Thereafter, the mixture with the phage added may be thinly applied to a plastic packaging material and naturally dried at room temperature to manufacture a dried coating composition.

[0035] In the present invention, based on the total volume of the coating composition, the bacteriophage is 10 4 10 inland 12 It may be included as PFU / ml, preferably 6×10 8 6×10 10It may include PFU / ml, but is not limited to this as long as it is within the range of sterilizing effect.

[0036] The coating composition of the present invention may further include additives such as wetting agents and preservatives, as needed. Furthermore, a solvent may be added for coating purposes and used in solution form. The volume of the composition may be based on the total volume of the solution. Water or an organic solvent may be used as the solvent, and an appropriate solvent may be used depending on the type of coating material and the intended application. Specifically, when the coating composition of the present invention is applied to food, water may be used as the solvent.

[0037] As one aspect for achieving the above object, the present invention provides an antibacterial film manufactured using the above coating composition.

[0038] The above 'coating composition' is as described above.

[0039] In the present invention, the antibacterial film can be manufactured using the coating composition, i.e., a coating composition comprising a bacteriophage stabilizing composition, bacteriophage, and a coating material. In this case, the coating composition can be used in the form of a solution containing a solvent for coating properties.

[0040] In the present invention, the antibacterial film can be manufactured by coating the coating composition on the coating target and then drying at a temperature of 20 to 30°C for 10 to 20 hours. When the film is manufactured in the form of a single film, it can be manufactured using a method of coating a solution by a method such as casting. For example, it can be manufactured by coating the coating composition under conditions of a relative humidity of 30 to 70 RH% and then drying at a temperature of 20 to 30°C for 10 to 20 hours.

[0041] In the present invention, the film can be interpreted to mean both a film in the form of being directly coated on a coating target such as a food such as an egg or a food container, and a single film form.

[0042] Specifically, the antibacterial film can be formed by adding bacteriophage and a coating material to a solution containing the stabilizing composition of the present invention, coating the solution on a target object or substrate, and then drying the solution. The solution can be diluted as needed.

[0043] As one aspect for achieving the above object, the present invention provides a food packaging material including the antibacterial film.

[0044] The above 'antibacterial film' is as described above.

[0045] As one aspect for achieving the above object, the present invention provides a method for sterilizing food or food material, comprising a step of treating the food or food material with the bacteriophage composition.

[0046] The above 'bacteriophage composition' is as described above.

[0047] Specifically, the sterilization method may include a step of dripping, immersing, or spraying the bacteriophage composition onto food or food materials contaminated with bacteria; or a step of washing the food or food materials contaminated with bacteria with a washing solution containing the bacteriophage composition and water. The bacteriophage composition may be prepared in the form of a bacteriophage concentrate, and may also be applied to food or food materials that are at risk of being contaminated with bacteria.

[0048] In the present invention, the 'bacteria' may be Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus or Cronobacter sakazakii, and may be Escherichia coli or Staphylococcus aureus, but is not limited thereto.

[0049] In the present invention, the 'food' may include all of meat, seafood, fruits or vegetables, and specifically, may include, but is not limited to, strawberries, cabbage, Brussels sprouts, broccoli, etc., which are difficult to wash, and may include any food that may be exposed to bacterial contamination.

[0050] As one aspect for achieving the above object, the present invention provides a sterilization method comprising the steps of placing food or food ingredients into a container packaged with the food packaging material; and the step of bringing the container into contact with water.

[0051] The above ‘bacteria’, ‘food’ and ‘food packaging material’ are as described above.

[0052] In the present invention, the food or food material may be a food or food material that is contaminated or is likely to be contaminated with bacteria.

[0053] In the present invention, when a container packaged with the food packaging material is brought into contact with water, the bacteriophage coated on the packaging material may be washed away, thereby sterilizing harmful bacteria in the food contained within the container.

[0054]

[0055] Hereinafter, the present invention will be described in more detail through examples. These examples are intended solely to illustrate the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples.

[0056] The composition for stabilizing bacteriophage according to the present invention can be commercialized and stored in a more convenient, economical, and efficient manner even at room temperature compared to conventional bacteriophage storage methods, and by manufacturing a bacteriophage composition including the composition for stabilizing bacteriophage or a packaging material coated with bacteriophage, etc., it has the effect of being directly applied to food for biological control, and can be usefully used for preventing bacterial contamination of food and maintaining food safety.

[0057] Figure 1 shows the results of confirming the degree of activity maintenance when Escherichia coli phage (A, B) and Staphylococcus aureus phage (C, D) were stored in SM buffer at room temperature (A, C) and refrigerated temperature (B, D), and when stored in saline, distilled water, and tap water.

[0058] Figure 2 shows the results of comparing the degree of activity maintenance when E. coli phage (A) and Staphylococcus aureus phage (B) were stored in distilled water and when stored in distilled water containing NaCl and MgSO4.

[0059] Figures 3A and 3B show the results comparing the degree of activity maintenance when E. coli phage (A) and Staphylococcus aureus phage (B) were stored in distilled water and when stored in distilled water containing sorbitol, sucrose, and maltose, respectively.

[0060] Figures 3C and 3D show the results of confirming the degree of maintenance of antibacterial activity when E. coli phage (C) and Staphylococcus aureus phage (D) are stored for a long period of time in distilled water containing sorbitol.

[0061] Figures 4A and 4B show the results comparing the degree of antibacterial activity maintained when storing E. coli phage (A) and Staphylococcus aureus phage (B) in i) distilled water containing nothing, ii) distilled water containing only sorbitol, iii) distilled water containing only NaCl and MgSO4, and iv) distilled water containing both sorbitol, NaCl, and MgSO4. (**p<0.01, ***p<0.001, ****p<0.0001)

[0062] Figures 4C and 4D show the results of confirming the degree of phage activity maintenance when E. coli phage (C) and Staphylococcus aureus phage (D) are stored in distilled water containing the stabilizing composition of the bacteriophage of the present invention (sorbitol + NaCl and MgSO4).

[0063] Figure 5 shows the results of comparing the growth of E. coli treated with phage to confirm that the phage stored in the stabilizing composition of the present invention has the same bacterial inhibitory activity as a general phage lysate stored in TSB medium. (***p<0.001)

[0064] Figure 6 shows the results of confirming the degree of E. coli death when a bacteriophage concentrate containing the stabilizing composition of the present invention was dripped onto vegetables (strawberry: A, cabbage: B). (*p<0.05, **p<0.01, ***p<0.001)

[0065] Figure 7 shows the results of confirming the effect of killing E. coli after washing when using a bacteriophage concentrate containing the stabilizing composition of the present invention as a detergent. (*p<0.05)

[0066] Figure 8 shows the results of comparing the effects of each candidate material on phage (E. coli phage: A, Staphylococcus aureus phage: B) stability to select an appropriate coating material for manufacturing a stabilizing composition and a phage-coated container of the present invention.

[0067] Figure 9 shows the results comparing the effects on phage (E. coli phage: A, Staphylococcus aureus phage: B) stability when the stabilizing composition of the present invention is mixed with pullulan or CMC.

[0068] Figure 10 shows the results of confirming the effect on phage stability under room temperature (A, B) and refrigerated (C, D) conditions when the stabilizing composition of the present invention is coated with pullulan and dried. (E. coli phage: A and C, Staphylococcus aureus phage: B and D)

[0069] Figure 11 shows the results of confirming the pathogen killing effect when washing vegetables (Brassica napus: A, broccoli: B) contaminated with pathogens using a stabilizing composition and a phage-coated container of the present invention. (*p<0.05, ***p<0.001)

[0070] Hereinafter, the present invention will be described in more detail through the following examples. However, these examples are intended to exemplify the present invention and the scope of the present invention is not limited to these examples.

[0071]

[0072] Example 1: Confirming the Need for Development of Bacteriophage Stabilizers

[0073] 1.1. Experimental Method

[0074] 1.1.1. Strains

[0075] E. coli phage vB_EcoM_LEC1 (accession no. KCTC 15076BP) and Staphylococcus aureus phage vB_SauH_LSA5 (accession no. KCTC 15395BP) strains were isolated by the present inventors from sewage and sewage treatment plants located in Iksan and Gimje, Jeollabuk-do, Republic of Korea. The purified LEC1 and LSA5 phages were stored at 4°C in Tryptic Soy Broth (TSB) medium composed of 17 g / L casein, 3 g / L papain digest of soybeans, 2.5 g / L dextrose, 5 g / L sodium chloride, and 2.5 g / L dipotassium phosphate. Phage titers were determined using the classic double agar overlay assay (Adams, 1959).

[0076] Samples were serially diluted 10-fold with SM buffer (0.1 M NaCl, 8 mM MgSO4·7H2O, and 50 mM Tris-HCl, pH 7.5), and 10 μl was spotted onto agar plates containing bacterial strains (E. coli NCTC 12079 for LEC1 and S. aureus ATCC 25923 for LSA5). After incubation at 37°C for 8 h for LEC1 and 16 h for LSA5, the number of plaques was counted. If no plaques were formed, 'not detected (ND)' was indicated in the bar graph and '1' was indicated on the vertical axis in the line graph according to the logarithmic scale.

[0077]

[0078] 1.1.2. Preservation of bacteriophages in various dispersions and temperatures

[0079] To prepare phage suspensions, 2 ml of LEC1 and LSA5 lysates were pipetted into a Pierce protein concentrator (100K, MWCO) and centrifuged at 6000 × g for 30 min at 25°C. Twenty ml of distilled water was added to wash the solution three times and centrifuged. The concentrated phages were resuspended in distilled water to an appropriate concentration. Four different solutions were used for phage suspension: sodium chloride-magnesium sulfate (SM) buffer (0.1 M NaCl, 8 mM MgSO4·7H2O, and 50 mM Tris-HCl, pH 7.5), saline solution (3M diluent), tap water, and distilled water. The number of plaques produced by phages stored in each solution at room temperature or refrigerated temperature was measured over time.

[0080]

[0081] 1.2. Confirmation of the necessity of developing a bacteriophage stabilizer

[0082] When bacteriophages are stored in buffer, their activity remains stable, but buffers cannot be used for food. To determine how the type of solution and storage temperature affect the stability of bacteriophages, bacteriophages were stored in two food-compatible solutions (saline, distilled water, or tap water) at different temperatures (4°C and room temperature), and the number of phages was measured over time. Bacteriophages stored in SM buffer served as a positive control, and the effects were compared.

[0083]

[0084] 1.2.1 E. coli phage

[0085] When stored at room temperature for 8 weeks, E. coli phages maintained phage stability only when stored in SM buffer, and decreased activity when stored in salt water, distilled water, or tap water. Phage titers in salt water or distilled water were 5.25 X 10, respectively, after 20 days of storage. 3 PFU / ml, 1.03Х10 3 PFU / ml, which is the initial value of 10 8 The PFU / ml corresponded to more than half of the logarithmic scale. Their activity was confirmed to completely decline after approximately 30 days. Furthermore, for phages stored in tap water, activity remained relatively high, but a tendency to decrease over time was observed (Fig. 1A).

[0086] Meanwhile, when E. coli phages were stored in a refrigerator (4°C), the number of active phages was maintained similar to the initial concentration regardless of the type of dispersion solution, and it was confirmed that it did not decrease even after 56 days (Fig. 1B).

[0087]

[0088] 1.2.2. Staphylococcus aureus phage

[0089] Staphylococcus aureus phages exhibited relatively low stability under most conditions. Specifically, when stored at room temperature, they lost all activity after 3 days in tap water, 7 days in salt water, and 14 days in distilled water (Fig. 1C).

[0090] In addition, when stored at a refrigerated temperature of 4℃, the activity was maintained more than when stored at room temperature, but overall, the activity tended to decrease except when stored in SM buffer (Fig. 1D).

[0091]

[0092] As confirmed in the results of section 1.2 above, the activity of phages stored in solutions applicable to the food used in the experiment decreased with increasing storage time, and the decrease was greater when stored at room temperature than when stored under refrigeration. Therefore, the development of alternative storage technologies was identified as necessary for room temperature storage.

[0093]

[0094] Example 2: Preparation of a composition for stabilizing bacteriophage

[0095] 2.1. Confirmation of the effects of NaCl and MgSO4

[0096] To confirm the effects of NaCl and MgSO4 in the storage of bacteriophages, distilled water was used as a control group, and the degree of activity maintenance when bacteriophages were stored in distilled water containing NaCl and MgSO4 was compared.

[0097] Specifically, 0.1 M NaCl (Sigma-Aldrich) and 8 mM MgSO4·7H2O (Sigma-Aldrich) were dissolved in distilled water, respectively, and filtered (0.45 μm). The titer of E. coli phage dispersed and stored in distilled water with added NaCl and MgSO4 at room temperature was 2.70 X 10 on the 63rd day, which was the initial titer. 7 7.75Х10 in PFU / ml 6 PFU / ml, and it was confirmed that there was almost no decrease. On the other hand, in contrast to the addition of the above ions, in the case of phages stored only in distilled water without ions, the initial titer decreased to 1.80Х10 on the 7th day of storage. 7 It was confirmed that the PFU / ml was reduced by half and all activity was completely lost on the 40th day (Fig. 2A).

[0098] Meanwhile, similar results were observed for the Staphylococcus aureus phage. Specifically, when stored only in distilled water, its titer rapidly decreased and all activity was lost on the 20th day of storage. On the other hand, when stored in distilled water with added NaCl and MgSO4, the phage activity was maintained until the 63rd day, and its titer was 3.50X10, which was slightly decreased from the initial value. 4 PFU / ml was shown (Fig. 2B).

[0099] From the above results, it was demonstrated that the addition of ions such as NaCl and MgSO4 acted as stabilizers, allowing the phage to maintain good residual titer and activity even after storage for more than two months.

[0100]

[0101] 2.2. Selection of sugar components and confirmation of effectiveness

[0102] Since the addition of ions in the above 2.1 slightly reduced phage activity, the possibility of using sugars as stabilizers for long-term phage storage was further investigated. D-sorbitol (Sigma-Aldrich), D-(+)-maltose monohydrate (Sigma-Aldrich), and sucrose (Sigma-Aldrich) were dissolved in distilled water at a final concentration of 10% (w / v). After mixing with a magnetic bar for 1 hour, the solution was filtered (0.45 μm).

[0103] To determine the effect of sugars on the storage of bacteriophages, distilled water (DW) was used as a control, and E. coli phages were stored in distilled water containing 10% sorbitol, 10% sucrose, and 10% maltose, respectively. All solutions were stored at room temperature, and the number of plaques of active phages stored in each solution was measured over time to compare the degree of phage activity maintenance. As a result, it was confirmed that E. coli phages maintained stability better when sorbitol or sucrose was added than in the negative control. In particular, it was confirmed that the stability maintenance effect was better when sorbitol was added than when sucrose was added. However, the addition of maltose inactivated the phages more quickly than the control (Fig. 3A).

[0104] The addition of maltose also failed to function as a stabilizer for Staphylococcus aureus phages. On the 6th day of storage, active phages were counted only in solutions containing sorbitol or sucrose. Because the stability of Staphylococcus aureus phages is lower, the effect was greater when sorbitol or sucrose was added. Meanwhile, on the 24th day of storage, no phage plaques were detected except in distilled water containing sorbitol (Fig. 3B). The effect of sorbitol was observed to be maintained for both E. coli phages (Fig. 3C) and Staphylococcus aureus (Fig. 3D) phages over the 63-day observation period. These results suggest that among sugars, sorbitol is the most effective additive for maintaining bacteriophage activity and exhibiting excellent residual titers.

[0105]

[0106] 2.3. Effect of mixing NaCl, MgSO4, and sorbitol

[0107] In order to determine the effect of mixing the salt (NaCl and MgSO4) of 2.1 and the sugar (sorbitol) of 2.2 (hereinafter referred to as the 'stabilizing composition') in the storage of bacteriophage, a bacteriophage dispersion aqueous solution was stored under conditions in which the stabilizer of 2.1 and the stabilizer of 2.2 were used alone or simultaneously.

[0108] Although E. coli phages maintained stable activity even under conditions where only ions were added, the number of active phages was observed to be greater when both sugars and ions were treated. In fact, when NaCl, MgSO4, and sorbitol were used simultaneously, the number of active phages did not decrease until the 63rd day of storage (Fig. 4A). In the case of Staphylococcus aureus phages, the effect of treating both sugars and ions was clearly observed (Fig. 4B). Consequently, in the case of the stabilizing composition using both sugars and ions, the activity maintenance effect was overwhelmingly high for both E. coli phages (Fig. 4C) and Staphylococcus aureus phages (Fig. 4D), and although there was a slight decrease in activity, activity was maintained for up to 48 weeks at room temperature.

[0109] Bacteriophage products sold as food additives have a shelf life of six months to one year, even when refrigerated. The fact that the bacteriophage stored at room temperature in the present invention maintained activity for a similar period suggests that the stabilizing composition of the present invention can enhance the stability of bacteriophage.

[0110]

[0111] 2.4. Confirmation of bacterial growth inhibition activity

[0112] In order to confirm whether the phage stored in the stabilizing composition of the present invention has the same bacterial inhibitory activity as the phage lysate (refrigerated in TSB medium) of the same concentration, the growth degree of E. coli treated with the phage was compared. Specifically, the E. coli NCTC 12079 culture was diluted 10,000-fold and stored in the stabilizing solution of the present invention, i.e., the stabilizing composition, for 175 days at room temperature (3.6 X 10 6 PFU / ml) and were mixed so that the MOI (Multiplicity of Infection, the number of phages per bacterial number) was approximately 1. 6Х10 6 Phage lysate at a concentration of PFU / ml was used as a positive control. Instead of phage, TSB was used as a negative control. After shaking culture at 37°C for 2 hours, colony counts were measured using EC film.

[0113] After 2 hours of incubation, the number of bacterial colonies treated with phage lysate was 4.17 log (4.2Х10 6 2.8Х10 in CFU / ml 2 CFU / ml). In addition, when the stabilizing composition and the phage stored for a long period (175 days) were treated, the number of bacteria was reduced to 4.04 log (4.2Х10 6 3.8Х10 in CFU / ml 2 CFU / ml) was reduced (Fig. 5).

[0114] Considering that the phage lysate used in the experiment had a slightly higher titer, the bacterial reduction rates can be interpreted as being similar in both cases. Consequently, it was confirmed that the phages dispersed in the stabilizing composition not only maintained long-term activity but also exhibited quantitatively equivalent antibacterial activity.

[0115]

[0116] Example 3: Confirmation of the effectiveness of a bacteriophage concentrate containing a composition for stabilizing bacteriophage.

[0117] 3.1. Application to food - When dripping onto food

[0118] All materials, including the dispersion and stabilizing composition used in this experiment, are applicable to food, and since the phage is preserved in liquid form, the stored phage product can be applied directly to food without separate treatment.

[0119] To determine the direct effect of phage products on controlling pathogens in fresh vegetables, strawberries and cabbage were artificially contaminated with pathogenic Escherichia coli. Strawberries, kimchi cabbage, and Brussels sprouts were purchased from a local grocery store in Jeonju, South Korea, washed with tap water, and air-dried. A 1,000-fold diluted culture of E. coli NCTC 12079 was spotted onto each kimchi and cabbage, and spread evenly across the entire surface.

[0120] Escherichia coli phage 6Х10 stored in distilled water containing the stabilizing composition of the present invention, i.e., 0.1 M NaCl, 8 mM MgSO4·7H2O and 10% (w / v) sorbitol (hereinafter, 'stabilizing solution') 10 PFU / ml was diluted 10- to 100-fold with a stabilizing solution to achieve a multiplicity of infection (MOI) of 10,000, an MOI of 1,000, and an MOI of 100, respectively. 100 μl of each solution was dropped onto the surfaces of strawberries and cabbages contaminated with E. coli and spread over the entire surface. A stabilizing solution containing no phages served as a negative control. After 30 minutes, the number of E. coli remaining on the vegetables was measured using an EC film (3M).

[0121] E. coli phages dispersed in distilled water containing 0.1 M NaCl, 8 mM MgSO4·7H2O, and 10% (w / v) sorbitol reduced the number of contaminated E. coli in a concentration-dependent manner. The number of pathogenic E. coli contaminated on strawberries was confirmed to be reduced by 72%, 83%, and 94%, respectively, when treated with phages at MOIs of 100, 1,000, and 10,000, compared to the control group to which only the stabilizing solution was added without phage (Fig. 6A). In the case of cabbage, the phage solution was also effective in reducing the number of E. coli on the cabbage surface at all concentrations. At the lowest dose of MOI 100, E. coli was reduced by 81% compared to the control group, and at MOIs of 1,000 and 10,000, E. coli was reduced by 96% and 98%, respectively, confirming the bactericidal effect (Fig. 6B).

[0122]

[0123] 3.2. Application to food - When used as a detergent

[0124] The antibacterial activity and convenience of the phage product with enhanced stability of the present invention were verified for difficult-to-wash vegetables. Brussels sprouts were artificially contaminated by applying 20 μl of a 1,000-fold dilution of a culture of pathogenic Escherichia coli NCTC 12079 to each cut surface ten times. The E. coli-contaminated vegetables were left at room temperature for 60 minutes before applying the phage solution.

[0125] To prepare a vegetable washing solution containing bacteriophages, 5 ml of E. coli phages stored in a stabilizing solution were added to 45 ml of tap water. Brussels sprouts contaminated with E. coli were placed in a sample cup containing the washing solution. Tap water mixed with a stabilizing solution without phages served as a negative control. After 10 minutes, the number of E. coli remaining on the vegetables was measured using an EC film (3M).

[0126] If washed only with tap water, 3.0Х10 from Brussels sprouts immediately after washing3 CFU / ml of E. coli remained. On the other hand, 2.12Х10 2 Contaminated E. coli remained at CFU / ml, a 93% reduction compared to the control group. Even when the Brussels sprouts were stored in the refrigerator for 24 hours after washing, the antibacterial activity by phages persisted, confirming that the killing effect persisted even after storage after washing (Fig. 7).

[0127]

[0128] Example 4: Confirmation of the effectiveness of a bacteriophage-coated cleaning packaging material including a composition for stabilizing bacteriophage.

[0129] 4.1. Selection of film coating material for packaging materials

[0130] To select films for bacteriophage-coated cleaning packaging, the types of film coating materials, i.e., i) pullulan, ii) carboxymethyl cellulose (CMC), iii) polyvinyl alcohol (PVA), iv) corn starch, and v) whey protein concentrate (WPC), were used as candidates, and the activity of bacteriophages for each was compared.

[0131] Specifically, for pullulan, a coating solution was prepared by dissolving 2.5 g of pullulan powder in distilled water to a final volume of 50 ml. For CMC, a coating solution was prepared by adding 0.5 g of powder to distilled water with 0.5 g of glycerol and 0.125 g of Tween80 to a final volume of 50 ml. For PVA, a coating solution was prepared by dissolving it in distilled water to a final concentration of 5% (w / v). Each material was mixed, heated, and stirred using a magnetic bar.

[0132] For corn starch, 7.5 g of starch and 3 g of glycerol were dissolved in distilled water to a final volume of 100 ml, heated, stirred at 300 rpm for 30 min, and then cooled before adding phage. For WPC, distilled water containing 10% WPC was stirred for 30 min, and 3:1 w / w glycerol was added to the mixture. The mixture was placed in a 90°C water bath, homogenized at 5,000 rpm for 4 min, and then immersed in an ice bath for cooling. After cooling, the homogenization was repeated at 5,000 rpm for 4 min and degassed using an ultrasonic bath for 30 min.

[0133] All materials prepared in a coating solution state were filtered (0.45 μm) and phage was added. 500 μl of the phage-added coating solution was dispensed into a 6-well microplate and stored in a desiccator for drying. For rehydration, 1 ml of buffer was mixed and shaken for 15 minutes. The number of bacteriophage plaques was counted using a double-layered plaque assay.

[0134] As a result, among the candidate materials, WPC and corn starch formed highly turbid films and remained as small particles even after rehydration. In contrast, pullulan, CMC, and PVA formed transparent, uniform films suitable for phage coating. Therefore, these three materials were selected for the next step.

[0135] It was confirmed that the phage dried with the above coating material was more stable than the phage dried with tap water. All three coating materials were effective in stabilizing the phage, but CMC was confirmed to be the most suitable for the E. coli phage (Fig. 8A) and pullulan was confirmed to be the most suitable for the Staphylococcus aureus phage (Fig. 8B). However, when mixed with the stabilizing composition of the present invention, the use of pullulan was confirmed to be more effective in stabilizing the E. coli and Staphylococcus aureus phages (Fig. 9). Therefore, pullulan was selected and used as a coating material in the preparation of the coating composition below.

[0136]

[0137] 4.2. Addition of stabilizing composition to pullulan-coated phage

[0138] A final 5% pullulan, 10% sorbitol, 0.1 M sodium chloride, and 8 mM MgSO4·7H2O were added to distilled water. After heating and mixing for 1 h using a magnetic stirrer, the solution was filtered through a 0.45 μm filter. Phage was added to the mixture, and 500 μl was dispensed into a 6-well plate and stored at room temperature for air drying. For rehydration, 1 ml of buffer was mixed and shaken for 15 min. The number of bacteriophage plaques was counted using a double-layered plaque assay.

[0139] Since the addition of the stabilizing composition of the present invention is effective in stabilizing phage in an aqueous solution, it was confirmed whether phage stability could be maintained even in a dried state. As shown in Fig. 10A, in the case of E. coli phage coated with pullulan and the stabilizing composition, the phage titer was maintained similar to the initial value even on the 7th day of storage (1.2Х10 9 2.3Х10 in PFU / ml 8PFU / ml), significant activity was maintained even after 43 days of storage (Fig. 10A). However, when the stabilizing composition was not included, i.e., only pullulan was coated, the number of phage plaques decreased by about 6 logs (1.1х10 9 7.4Х10 in PFU / ml 2 PFU / ml) was significantly reduced, and after 14 days, almost no active bacteriophage was observed. In addition, in the case of Staphylococcus aureus phage with relatively low stability, in the case of the control group without stabilizing composition, all activity was lost on the 7th day of storage, but in the case of the stabilizing composition added, stability was confirmed for up to 7 days of storage (6.8Х10 7 6.6Х10 in PFU / ml 6 PFU / ml), and exhibited significant activity even after long-term storage (Fig. 10B). In addition, when stored at refrigerated temperatures with the addition of a stabilizing composition, both types of bacteriophages maintained high stability for up to 43 days, and in particular, the plaque concentration of the E. coli phage was confirmed to decrease minimally (Figs. 10C and 10D).

[0140] Therefore, it was confirmed that the stabilizer was effective in maintaining the stability of the phage even in a dry state.

[0141]

[0142] 4.3. Application to food

[0143] A 2 ml pullulan coating solution containing a stabilizing composition and E. coli phage was dispensed into a plastic cup and dried. Brussels sprouts and broccoli, vegetables difficult to clean, were purchased from a local market, and the cut surfaces of the Brussels sprouts and broccoli were artificially contaminated with pathogenic Escherichia coli (E. coli). Twenty ml of tap water was added to the phage-coated container, and the contaminated vegetables were placed in the cup and shaken. After 10 minutes, the number of E. coli remaining on the vegetables was measured using EC film (3M).

[0144] It was expected that the coating would dissolve in tap water, and the contaminated E. coli would be killed by the released phages. A negative control group coated only with pullulan and a stabilizing composition without phages was used. As a result, compared to the control group, washing with phage-coated containers resulted in a 91% and 97% reduction in pathogenic E. coli in Brussels sprouts (Figure 11A) and broccoli (Figure 11B), respectively, confirming that washing with phage-coated containers was more effective in reducing E. coli counts.

[0145]

[0146] From the above description, those skilled in the art will understand that the present invention can be implemented in other specific forms without altering its technical spirit or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of the present invention should be interpreted as encompassing all changes or modifications derived from the meaning and scope of the following claims and their equivalent concepts, rather than the detailed description above.

Claims

1. A composition for stabilizing bacteriophage, comprising sorbitol, sodium chloride and magnesium sulfate.

2. In paragraph 1, A composition for stabilizing a bacteriophage, wherein the bacteriophage has a specific killing ability against Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus, or Cronobacter sakazakii.

3. In paragraph 1, A composition for stabilizing bacteriophage, wherein the above sorbitol is included at a concentration of 5 to 20% (w / v).

4. A bacteriophage composition comprising a composition for stabilizing bacteriophage according to paragraph 1.

5. In paragraph 4, A bacteriophage composition, wherein the bacteriophage has a specific killing ability against Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus, or Cronobacter sakazakii.

6. In paragraph 4, The above bacteriophage composition comprises 10 of the above bacteriophages. 4 10 inland 12 A bacteriophage composition comprising PFU / ml.

7. A coating composition comprising a composition for stabilizing a bacteriophage according to paragraph 1, a bacteriophage, and a coating material.

8. In paragraph 7, A coating composition, wherein the bacteriophage has a specific killing ability against Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus, or Cronobacter sakazakii.

9. In paragraph 7, A coating composition wherein the coating material is pullulan, carboxymethyl cellulose or polyvinyl alcohol.

10. In paragraph 9, A coating composition wherein the coating material is pullulan or carboxymethyl cellulose.

11. An antibacterial film manufactured using the coating composition according to Article 7.

12. Food packaging material comprising the antibacterial film of Article 11.

13. A method for sterilizing food or food materials, comprising a step of treating the food or food materials with a bacteriophage composition according to Article 4.

14. A method for sterilizing food or food materials, comprising the steps of placing food or food materials into a container packaged with food packaging material according to Article 12; and the step of bringing the container into contact with water.

15. In paragraph 13 or 14, The above method is a sterilization method for sterilizing Escherichia coli, Staphylococcus aureus, Salmonella, Bacillus cereus, Listeria monocytogenes, Vibrio parahaemolyticus or Cronobacter sakazakii.

Citation Information

Patent Citations

  • Bacteriophage-containing spray type environment disinfectant as well as preparation method and application thereof

    CN111316999A

  • Bacteriophage s8 and the use thereof

    KR1020180106345A

  • Display device and method of manufacturing the same

    KR1020240080638A

  • Coating Composition Comprising Bacteriophage and Antibacterial Film Formed by Using Same

    KR102526744B1

  • Bacteriophage compositions

    US20210121510A1